196 related articles for article (PubMed ID: 21069546)
1. Combined effects of soy isoflavone and fish oil on ovariectomy-induced bone loss in mice.
Uchida R; Chiba H; Ishimi Y; Uehara M; Suzuki K; Kim H; Matsumoto A
J Bone Miner Metab; 2011 Jul; 29(4):404-13. PubMed ID: 21069546
[TBL] [Abstract][Full Text] [Related]
2. Combined intervention of soy isoflavone and moderate exercise prevents body fat elevation and bone loss in ovariectomized mice.
Wu J; Wang X; Chiba H; Higuchi M; Nakatani T; Ezaki O; Cui H; Yamada K; Ishimi Y
Metabolism; 2004 Jul; 53(7):942-8. PubMed ID: 15254891
[TBL] [Abstract][Full Text] [Related]
3. The combined effects of soya isoflavones and resistant starch on equol production and trabecular bone loss in ovariectomised mice.
Tousen Y; Matsumoto Y; Matsumoto C; Nishide Y; Nagahata Y; Kobayashi I; Ishimi Y
Br J Nutr; 2016 Jul; 116(2):247-57. PubMed ID: 27197747
[TBL] [Abstract][Full Text] [Related]
4. Kanamycin inhibits daidzein metabolism and abilities of the metabolites to prevent bone loss in ovariectomized mice.
Katsumata S; Fujioka M; Fujii S; Takeda K; Ishimi Y; Uehara M
BMC Res Notes; 2016 Jul; 9():334. PubMed ID: 27388904
[TBL] [Abstract][Full Text] [Related]
5. A combination of dietary fructooligosaccharides and isoflavone conjugates increases femoral bone mineral density and equol production in ovariectomized mice.
Ohta A; Uehara M; Sakai K; Takasaki M; Adlercreutz H; Morohashi T; Ishimi Y
J Nutr; 2002 Jul; 132(7):2048-54. PubMed ID: 12097691
[TBL] [Abstract][Full Text] [Related]
6. Dietary n-3 fatty acids decrease osteoclastogenesis and loss of bone mass in ovariectomized mice.
Sun D; Krishnan A; Zaman K; Lawrence R; Bhattacharya A; Fernandes G
J Bone Miner Res; 2003 Jul; 18(7):1206-16. PubMed ID: 12854830
[TBL] [Abstract][Full Text] [Related]
7. [Soy isoflavones with supplemental calcium provide protection against the loss of bone mass and influence insulin-like growth factor (IGF)-I after ovariectomy in rat].
Cheng MW; Liu JF; Yi GQ; Zhang XP; Zhu QH; Liu LG
Zhonghua Yu Fang Yi Xue Za Zhi; 2006 Sep; 40(5):328-31. PubMed ID: 17166423
[TBL] [Abstract][Full Text] [Related]
8. Modulation of soy isoflavones bioavailability and subsequent effects on bone health in ovariectomized rats: the case for equol.
Mathey J; Mardon J; Fokialakis N; Puel C; Kati-Coulibaly S; Mitakou S; Bennetau-Pelissero C; Lamothe V; Davicco MJ; Lebecque P; Horcajada MN; Coxam V
Osteoporos Int; 2007 May; 18(5):671-9. PubMed ID: 17333448
[TBL] [Abstract][Full Text] [Related]
9. Protective actions of soy isoflavones and n-3 PUFAs on bone mass in ovariectomized rats.
Watkins BA; Reinwald S; Li Y; Seifert MF
J Nutr Biochem; 2005 Aug; 16(8):479-88. PubMed ID: 16043030
[TBL] [Abstract][Full Text] [Related]
10. Bone-sparing effect of soy protein in ovarian hormone-deficient rats is related to its isoflavone content.
Arjmandi BH; Birnbaum R; Goyal NV; Getlinger MJ; Juma S; Alekel L; Hasler CM; Drum ML; Hollis BW; Kukreja SC
Am J Clin Nutr; 1998 Dec; 68(6 Suppl):1364S-1368S. PubMed ID: 9848500
[TBL] [Abstract][Full Text] [Related]
11. Soy moderately improves microstructural properties without affecting bone mass in an ovariectomized rat model of osteoporosis.
Devareddy L; Khalil DA; Smith BJ; Lucas EA; Soung do Y; Marlow DD; Arjmandi BH
Bone; 2006 May; 38(5):686-93. PubMed ID: 16406762
[TBL] [Abstract][Full Text] [Related]
12. Acute fish oil and soy isoflavone supplementation increase postprandial serum (n-3) polyunsaturated fatty acids and isoflavones but do not affect triacylglycerols or biomarkers of oxidative stress in overweight and obese hypertriglyceridemic men.
Hanwell HE; Kay CD; Lampe JW; Holub BJ; Duncan AM
J Nutr; 2009 Jun; 139(6):1128-34. PubMed ID: 19339704
[TBL] [Abstract][Full Text] [Related]
13. Effect of daidzein, a soy isoflavone, on bone metabolism in Cd-treated ovariectomized rats.
Om AS; Shim JY
Acta Biochim Pol; 2007; 54(3):641-6. PubMed ID: 17717607
[TBL] [Abstract][Full Text] [Related]
14. Dietary soy isoflavone-aglycone lowers food intake in female rats with and without ovariectomy.
Kishida T; Mizushige T; Ohtsu Y; Ishikawa S; Nagamoto M; Izumi T; Obata A; Ebihara K
Obesity (Silver Spring); 2008 Feb; 16(2):290-7. PubMed ID: 18239635
[TBL] [Abstract][Full Text] [Related]
15. Role of soy protein with normal or reduced isoflavone content in reversing bone loss induced by ovarian hormone deficiency in rats.
Arjmandi BH; Getlinger MJ; Goyal NV; Alekel L; Hasler CM; Juma S; Drum ML; Hollis BW; Kukreja SC
Am J Clin Nutr; 1998 Dec; 68(6 Suppl):1358S-1363S. PubMed ID: 9848499
[TBL] [Abstract][Full Text] [Related]
16. Genistein prevents bone resorption diseases by inhibiting bone resorption and stimulating bone formation.
Li B; Yu S
Biol Pharm Bull; 2003 Jun; 26(6):780-6. PubMed ID: 12808286
[TBL] [Abstract][Full Text] [Related]
17. Effects of soybean isoflavone dosage and exercise on the serum markers of bone metabolism in ovariectomized rats.
Liu K; Ma G; Lv G; Zou Y; Wang W; Liu L; Yan P; Liu Y; Jiang L; Liu Y; Liu Z
Asia Pac J Clin Nutr; 2007; 16 Suppl 1():193-5. PubMed ID: 17392103
[TBL] [Abstract][Full Text] [Related]
18. Fructooligosaccharides maximize bone-sparing effects of soy isoflavone-enriched diet in the ovariectomized rat.
Mathey J; Puel C; Kati-Coulibaly S; Bennetau-Pelissero C; Davicco MJ; Lebecque P; Horcajada MN; Coxam V
Calcif Tissue Int; 2004 Aug; 75(2):169-79. PubMed ID: 15164148
[TBL] [Abstract][Full Text] [Related]
19. Effects of soy isoflavone and/or estrogen treatments on bone metabolism in ovariectomized rats.
Kim MS; Lee YS
J Med Food; 2005; 8(4):439-45. PubMed ID: 16379553
[TBL] [Abstract][Full Text] [Related]
20. A comparative study of the bone metabolic response to dried plum supplementation and PTH treatment in adult, osteopenic ovariectomized rat.
Smith BJ; Bu SY; Wang Y; Rendina E; Lim YF; Marlow D; Clarke SL; Cullen DM; Lucas EA
Bone; 2014 Jan; 58():151-9. PubMed ID: 24125756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
